Steris Plc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Steris Plc inventory turnover ratio, the Steris Plc's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 4.12 in the first quarter 2026, yet the ratio remained below the average, as STE31's market remain challenging.Average inventory processing period, for the Steris Plc in Jun 30 2026 quarter, has decreased to 89 days, compare to 90 days, in the Dec 31 2022 quarter.

Within Healthcare sector 106 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form in the third quarter 2023, to 1116.

STE31 Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Steris Plc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

STE31 Inventory Turnover Ratio	(Jun 30 2026) I. Quarter	(Dec 31 2022) III. Quarter	(Sep 30 2022) II. Quarter	(Jun 30 2022) I. Quarter	(Mar 31 2022) IV. Quarter
Y / Y Inventory Growth	23.84 %	82.5 %	14.24 %	4.61 %	82.5 %
Y / Y Cost of Sales Growth	26.53 %	-5.46 %	-15.07 %	6.58 %	29.44 %
Inventory Turnover Ratio (TTM)	4.12	4.07	4.63	5.02	5.02
STE31's Total Ranking	# 1116	#	#	#	#
Average inventory processing period	89	90	79	73	73
Seq. Inventory Growth	23.84 %	-10.84 %	3.95 %	7.9 %	82.5 %
Seq. Cost of Sales Growth	27.49 %	4.21 %	5.33 %	-9.58 %	-4.74 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 28
Healthcare Sector	# 107
Overall Market	# 1116

Inventory Turnover Ratio Statistics
High	Average	Low
9.66	6.63	4.07
(Dec 31 2019)		(Dec 31 2022)

STE31 Company Profile >> Back to STE31 Efficiency Comparisons >> Compare STE31 Inventory Turnover Ratio to its Competitors

Financial Statements
Steris Plc's Inventories	$ 712 Millions	Visit STE31's Balance sheet
Steris Plc's Cost of Revenues TTM	$ 2,629 Millions	Visit STE31's Income Statement
What are STE31's Sales?		Visit STE31's Sales by Segment

Other Inventory Turnover Ratios
Steris Plc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
STE31's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for STE31's Competitors
Inventory Turnover Ratio for STE31's Suppliers
Inventory Turnover Ratio for STE31's Customers

You may also want to know
STE31's Sales Growth Rates	STE31's Pe Price to earnings ratio	STE31's Receivables Turnover Ratio	STE31's Stock Quote
STE31's Net Income Growth Rates	STE31's Ps Price to Sales ratio	STE31's Sales per Employee	STE31's Asset Turnover Ratio
STE31's Net Margin	STE31's Pb Price to Book ratio	STE31's Financial Strength Ratios	STE31's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Lantheus Holdings Inc	10.09	$ 619.325 Millions	$ 61 Millions
Sotera Health Company	10.04	$ 547.412 Millions	$ 55 Millions
Edap Tms Sa	9.67	$ 62.351 Millions	$ 6 Millions
Natera Inc	9.46	$ 672.186 Millions	$ 71 Millions
Warby Parker Inc	9.27	$ 414.054 Millions	$ 45 Millions
Hims and Hers Health Inc	9.23	$ 814.411 Millions	$ 88 Millions
Polomar Health Services, Inc.	8.80	$ 1.233 Millions	$ 0 Millions
Myriad Genetics Inc	8.31	$ 250.700 Millions	$ 30 Millions
National Vision Holdings Inc	8.26	$ 841.416 Millions	$ 102 Millions
Castle Biosciences Inc	8.14	$ 81.252 Millions	$ 10 Millions
Autolus Therapeutics Plc	8.08	$ 99.009 Millions	$ 12 Millions
The Oncology Institute Inc	8.03	$ 160.655 Millions	$ 20 Millions
Nutriband Inc	7.92	$ 1.082 Millions	$ 0 Millions
Novavax inc	7.61	$ 88.541 Millions	$ 12 Millions
Inogen Inc	7.51	$ 196.617 Millions	$ 26 Millions
Moderna Inc	7.50	$ 1,707.000 Millions	$ 228 Millions
Cardiff Lexington Corporation	7.49	$ 4.042 Millions	$ 1 Millions
Pulse Biosciences Inc	7.45	$ 1.182 Millions	$ 0 Millions
Vanda Pharmaceuticals Inc	7.43	$ 13.506 Millions	$ 2 Millions
Carlsmed Inc	7.42	$ 13.955 Millions	$ 2 Millions
Adaptive Biotechnologies Corporation	7.26	$ 75.254 Millions	$ 10 Millions
Lifemd Inc	7.22	$ 22.284 Millions	$ 3 Millions
Phathom Pharmaceuticals Inc	7.01	$ 40.929 Millions	$ 6 Millions
Carlisle Companies Incorporated	6.94	$ 3,299.600 Millions	$ 476 Millions
Twist Bioscience Corporation	6.62	$ 207.413 Millions	$ 31 Millions
Brightspring Health Services Inc	6.35	$ 4,108.953 Millions	$ 647 Millions
Puma Biotechnology Inc	6.29	$ 58.199 Millions	$ 9 Millions
Kewaunee Scientific Corporation	6.12	$ 196.836 Millions	$ 32 Millions
Adm Tronics Unlimited Inc	6.05	$ 1.970 Millions	$ 0 Millions
Align Technology inc	6.00	$ 1,321.762 Millions	$ 220 Millions

Date modified: 2026-09-12T06:23:51+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.